Literature DB >> 15257106

Mechanisms of inhibition of growth of human pancreatic carcinoma implanted in nude mice by somatostatin receptor subtype 2.

Manoj Kumar1, Zheng-Ren Liu, Laxmi Thapa, Da-Yu Wang, Rui Tian, Ren-Yi Qin.   

Abstract

OBJECTIVES: Several studies reported that somatostatin receptor subtypes, especially subtype 2 (SSTR2), exerted their cytostatic and/or cytotoxic effects on various types of tumors. The aim of this study was to investigate the antitumor effect of SSTR2 gene transfer to the pancreatic cancer cell line PC-3 and the mechanisms involved in this effect.
METHODS: The full-length human SSTR2 cDNA was introduced into pancreatic cancer cell line PC-3 by lipofectamine-mediated transfection; positive clones were screened by G418, and stable expression of SSTR2 was detected by the immunohistochemical SABC method and RT-PCR. Athymic mice were separately xenografted with SSTR2-expressing cells (experimental group), vector control, and mock control cells. TUNEL assay was used to determine the apoptotic index (AI) in the tumors of these groups. The immunohistochemical SP method was used to determine expression of apoptosis-regulating genes Bcl-2 and Bax and re-expression of SSTR2 and to assess intratumoral microvessel density (MVD). Moreover, tumor volume and weight were compared among these 3 groups.
RESULTS: Restoration of SSTR2 was observed in the experimental group both in vitro and in vivo. The AI was significantly higher in the experimental group (3.39 +/- 0.84%) compared with that in the vector control (0.69 +/- 0.08%) and mock control (0.68 +/- 0.09%) (P < 0.05). MVD was significantly lower in the experimental group (6.30 +/- 1.71) than that in the vector control (12.64 +/- 1.69) and mock control (13.50 +/- 1.86) (P < 0.05). Furthermore, a significant decrease in Bcl-2 and increase in Bax protein expression were detected in the experimental group compared with the vector control and mock control (P < 0.05). A significant negative correlation of protein expression between Bcl-2/Bax ratio and SSTR2 was observed in these tumors (P < 0.05). Tumor volume and weight were significantly decreased in the experimental group compared with the vector control and mock control (P < 0.05) groups. However, no significant differences were observed between the vector control and mock control (P > 0.05).
CONCLUSION: Re-expression of the SSTR2 gene, the expression of which is frequently lost in human pancreatic adenocarcinoma, induces apoptosis, which may be mediated via down-regulation of Bcl-2 and up-regulation of Bax (alteration of Bcl-2/Bax ratio) and inhibits tumor angiogenesis in pancreatic carcinoma, resulting in inhibition of tumor growth.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15257106     DOI: 10.1097/00006676-200408000-00009

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  6 in total

1.  Somatostatin receptor subtype 2-mediated scintigraphy and localization using (99m)Tc-HYNIC-Tyr(3)-octreotide in human hepatocellular carcinoma-bearing nude mice.

Authors:  Yong Li; Jian-Ming Si; Jun Zhang; Jin Du; Fan Wang; Bing Jia
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

2.  Gene transfer of somatostatin receptor type 2 by intratumoral injection inhibits established pancreatic carcinoma xenografts.

Authors:  Zhi-Yong Du; Ren-Yi Qin; Wei Xia; Rui Tian; Manoj Kumar
Journal:  World J Gastroenterol       Date:  2005-01-28       Impact factor: 5.742

3.  Thrombospondin-1 is a critical effector of oncosuppressive activity of sst2 somatostatin receptor on pancreatic cancer.

Authors:  Hanane Laklai; Séverine Laval; Laurent Dumartin; Philippe Rochaix; Martin Hagedorn; Andreas Bikfalvi; Sophie Le Guellec; Marie-Bernadette Delisle; Andrew V Schally; Christiane Susini; Stéphane Pyronnet; Corinne Bousquet
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-01       Impact factor: 11.205

4.  Impact of Octreotide and SOM-230 on liver metastasis and hepatic lipidperoxidation in ductal pancreatic adenocarcinoma in Syrian Hamster.

Authors:  M Kilian; J I Gregor; I Heukamp; K Helmecke; M Hanel; B Wassersleben; M K Walz; I Schimke; G Kristiansen; F A Wenger
Journal:  Clin Exp Metastasis       Date:  2009-06-12       Impact factor: 5.150

5.  Somatostatin receptor 2 signaling promotes growth and tumor survival in small-cell lung cancer.

Authors:  Jonathan M Lehman; Megan D Hoeksema; Jeremy Staub; Jun Qian; Bradford Harris; J Clay Callison; Jennifer Miao; Chanjuan Shi; Rosana Eisenberg; Heidi Chen; Sheau-Chiann Chen; Pierre P Massion
Journal:  Int J Cancer       Date:  2018-10-09       Impact factor: 7.396

6.  The truncated somatostatin receptor sst5TMD4 stimulates the angiogenic process and is associated to lymphatic metastasis and disease-free survival in breast cancer patients.

Authors:  Manuel D Gahete; David Rincón-Fernández; Mario Durán-Prado; Marta Hergueta-Redondo; Alejandro Ibáñez-Costa; Alejandro Rojo-Sebastián; Francisco Gracia-Navarro; Michael D Culler; Oriol Casanovas; Gema Moreno-Bueno; Raúl M Luque; Justo P Castaño
Journal:  Oncotarget       Date:  2016-09-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.